References
- Kadin, M.E. (1994) "Pathology of Hodgkin's disease", Current Opinion in Oncology, 6, 456–463.
- Harris, N.L. (1999) "Hodgkin's disease: classification and differ-ential diagnosis", Modern Pathology, 12, 159— 175.
- Gruss, R.I., Herrmann, F. and Drexler, H.G. (1994) "Hodgkin's disease: a cytokine-producing tumor", Crit. Rev. Oncog., 5, 473 — 538.
- Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., et al. (1995) "Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell line", Blood, 85, 780— 789.
- Skinnider, B.F. and Mak, T.W. (2002) "The role of cytokines in classical Hodgkin lymphoma", Blood, 99, 4283–4297.
- Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Improta, S., et al. (1996) "Human Eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line", Blood, 88, 3299 — 3305.
- Aldinucci, D., Poletto, D., Nanni, P., Degan, M., Gloghini, A., Di Francia, R., et al. (2002) "Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor", Br. J. Haematol., 118, 1055–1064.
- Aldinucci, D., Poletto, D., Gloghini, A., Nanni, P., Degan, M., Per, T., et al. (2002) "Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells", Am. J. Pathol., 160, 585 — 596.
- Skinnider, B.F., Kapp, U. and Mak, T.W. (2002) "The role of interleukin 13 in classical Hodgkin lymphoma", Leuk. Lymphoma, 43, 1203–1210.
- Maggio, E., van den Berg, A., Diepstra, A., Kluiver, J., Visser, L. and Poppema, S. (2002) "Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues", Ann. OncoL, 13, 52–56.
- Fischer, M., Juremalm, M., Olsson, N., Backlin, C., Sundstrom, C., Nilsson, K., et al. (2003) "Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue", Int. J. Cancer, 107, 197 — 201.
- Poppema, S. (1996) "Immunology of Hodgkin's disease", Baillieres Clinical Haematology, 9, 447–457.
- Gruss, Hi., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997) "Hodgkin's disease: a tumor with disturbed immunological pathways", Immunology Today, 18, 156–163.
- Pinto, A., Gattei, V., Zagonel, V., Aldinucci, D., Degan, M., De Julius, A., et al. (1998) "Hodgkin's disease: a disorder of dysregulated cellular cross-talk", Biotherapy, 10, 309 — 320.
- Gloghini, A., Volpe, R. and Carbone, A. (1990) "Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid tissue", Human Pathology, 21, 792— 798.
- Ohshima, K., Sugihara, M., Suzumiya, J., Haraoka, S., Kanda, M., Shimazaki, K., et al. (1999) "Basic fibroblast growth factor and fibrosis in Hodgkin's disease", PathoL Res. Pract., 195, 149 — 155.
- Ward, PA. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123–129.
- Sime, P.J. and O'Reilly, K.M. (2001) "Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment", Clin. ImmunoL, 99, 308 — 319.
- Postlethwaite, A.E., Holness, M.A., Katai, H. and Raghow, R. (1992) "Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4", J. Clin. Invest., 90, 1479 — 1485.
- Gillery, P., Fertin, C., Nicolas, J.F., Chastang, F., Kalis, B., Banchereau, J., et al. (1992) "Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis", FEBS Lett., 18, 302, 231–234.
- Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. and Wynn, T.A. (1999) "An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory re-sponse", J. Clin. Invest., 104, 777–785.
- Oriente, A., Fedarko, N.S., Pacocha, SE., Huang, S.K., Lichten-stein, L.M. and Essayan, D.M. (2000) "Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts", J. PharmacoL Exp. Ther., 292, 988–994.
- Lee, C.G., Homer, R.J., Cohn, L., Link, H., Jung, S., Craft, J.E., et al. (2002) "Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways", J. Biol. Chem., 277, 35466— 35474.
- Gharaee-Kermani, M., Denholm, EM. and Phan, S.H. (1996) "Costimulation of fibroblast collagen and transforming growth factor betal gene expression by monocyte chemoattractant protein-1 via specific receptors", J. Biol. Chem., 271, 17779 — 17784.
- Gharaee-Kermani, M. and Phan, S.H. (1998) "The role of eosinophils in pulmonary fibrosis", Int. J. MoL Med., 1, 43–53.
- Ohshima, K., Akaiwa, M., Umeshita, R., Suzumiya, J., Izuhara, K. and Kikuchi, M. (2001) "Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involve-ment in fibrosis", Histopathology, 38, 368–375.
- Bun, C., Korner, M., Scharli, P., Cefai, D., Uguccioni, M., Mueller, C., et al. (2001) "CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease", Blood, 97, 1543 — 1548.
- Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K. and Takizawa, H. (2003) "Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro", Int. Arch. Allergy ImmunoL, 132, 168 — 176.
- Kelly, M., Kolb, M., Bonniaud, P. and Gaulclie, J. (2003) "Re-evaluation of fibrogenic cytokines in lung fibrosis", Curr. Pharm. Des., 9, 39 — 49.
- Marcopoulou, C.E., Vavouraki, H.N., Dereka, X.E. and Vrotsos, I.A. (2003) "Proliferative effect of growth factors TGF-betal, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells", J. Int. Acad. Periodontol., 5, 63–70.
- Takehara, K. (2000) "Growth regulation of skin fibroblasts", J. DermatoL Sci., 24, (Suppl 1),S70–77.
- Newcom, S.R. and Gu, L. (1995) "Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease", J. Clin. PathoL, 48, 160–163.
- Newcom, S.R., Kadin, M.E., Ansari, A.A. and Diehl, V. (1988) "L-428 nodular sclerosing Hodgkin's cell secretes a unique transform-ing growth factor-beta active at physiologic pH", J. Clin. Invest., 82, 1915–1921.
- Kadin, M.E., Agnarsson, B., Ellingsworth, L.R. and Newcom, S.R. (1990) "Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease", Am. J. PathoL, 136, 1209 — 1214.
- Kadin, M., Butmarc, J., Elovic, A. and Wong, D. (1993) "Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease", Am. J. Pathol., 142, 11–16.
- Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., et al. (1994) "The CD40 antigen and its ligand", Annu. Rev. Immunol., 12, 881–922.
- Brouty-Boye, D., Pottin-Clemenceau, C., Doucet, C., Jasmin, C. and Azzarone, B. (2000) "Chemokines and CD40 expression in human fibroblasts", Eur. J. Immunol., 30, 914 — 919.
- Fries, K.M., Sempowski, G.D., Gaspari, A.A., Blieden, T., Looney, R.J. and Phipps, R.P. (1995) "CD40 expression by human fibroblasts", Clin. Immunol. Immunopathol., 77, 42–51.
- Ward, P.A. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123— 129.
- Companjen, A.R., van der Wel, L.I., Boon, L., Prens, E.P. and Laman, J. D. (2002) "CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-I", Int. Immunol., 14, 669 — 676.
- Wassenaar, A., Verschoor, T., Kievits, F., Den Hartog, M.T., Kapsenberg, M.L., Everts, V., et al. (1999) "CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts", Clin. Exp. ImmunoL, 115, 161 — 167.
- King, A.E., Kelly, R.W., Critchley, HOD., Malmstrom, A., Sennstrom, M. and Phipps, R.P. (2001) "CD40 expression in uterine tissues: a key regulator of cytokine expression by fibro-blasts", J. Clin. EndocrinoL MeTable., 86, 405–412.
- Yellin, M.J., Winikoff, S., Fortune, S.M., Baum, D., Crow, M.K., Lederman, S., etal. (1995) "Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation", J. Leukoc. BioL, 58, 209 — 211.
- Atamas, S.P., Luzina, I.G., Dai, H., Wilt, S.G. and White, B. (2002) "Synergy between CD40 ligation and IL-4 on fibroblast prolifera-tion involves IL-4 receptor signalling", J. Immunol., 168, 1139 — 1145.
- Zhang, Y., Cao, H.J., Graf, B., Meekins, H., Smith, T.J. and Phipps, R.P. (1998) "CD40 engagement up-regulates cyclooxygen-ase-2 expression and prostaglandin E2 production in human lung fibroblasts", J. Immunol., 160, 1053 — 1057.
- Betz, M. and Fox, B.S. (1995) "Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines", J. ImmunoL, 146, 108 — 113.
- Clodi, K., Asgari, Z., Younes, M., Palmer, J.L., Cabanillas, F., Carbone, A., etal. (2002) "Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance", Cancer, 94, 1 — 5.
- Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Perin, V., etal., (1997) "The role of eosinophils in the pathobiology of Hodgkin's disease", Ann. OncoL, 8, 89— 96.
- Molin, D., Edstrom, A., Glimelius, I., Glimelius, B., Nilsson, G., Sundstrom, C., et al. (2002) "Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma", Br. J. HaematoL, 119, 122–124.
- Hartman, M.L., Piliponsky, A.M., Temkin, V. and Levi-Schaffer, F. (2001) "Human peripheral blood eosinophils express stem cell factor", Blood, 97, 1086— 1091.
- Bargou, R.C., Mapara, M.Y., Zugck, C., Daniel, P.T., Pawlita, M., Dohner, H., et al. (1993) "Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice", J. Exp. Med., 177, 1257— 1268.
- Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297— 303.
- Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., et al. (2001) "STAT3 is constitutively activated in Hodgkin cell lines", Blood, 98, 762–770.
- Ashman, L.K. (1999) "The biology of stem cell factor and its receptor C-kit", International Journal of Biochemistry and Cell Biology, 31, 1037–1051.
- Broudy, V.C. (1997) "Stem cell factor and hematopoiesis", Blood, 90, 1345–1364.
- Broxmeyer, H.E., Maze, R., Miyazawa, K., Carow, C., Hendrie, P.C., Cooper, S., et al. (1991) "The kit receptor and its ligand, steel factor, as regulators of hemopoiesis", Cancer Cells, 3, 480–487.
- Mierke, C.T., Ballmaier, M., Werner, U., Manns, M.P., Welte, K. and Bischoff, S.C. (2000) "Human endothelial cells regulate survival and proliferation of human mast cells", Journal of Experimental Medicine, 192, 801–811.
- Avraham, H., Scadden, D.T., CM, S., Broudy, V.C., Zsebo, K.M. and Groopman, J.E. (1992) "Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand", Blood, 80, 1679 — 1684.
- Gattei, V., Aldinucci, D., Quinn, J.M., Degan, M., Cozzi, M., Perin, V., et al. (1996) "Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor", Cell Growth & Differentiation, 7, 753–763.
- Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M.R., Ludwig, W.D., etal. (1992) "Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors", Blood, 80, 1199–1206.
- Timeus, F., Crescenzio, N., Valle, P., Pistamiglio, P., Piglione, M., Garelli, E., et al. (1997) "Stem cell factor suppresses apoptosis in neuroblastoma cell lines", Experimental Haematology, 25, 1253 — 1260.
- Ricotti, E., Fagioli, F., Garelli, E., Linari, C., Crescenzio, N., Horenstein, A.L., et al. (1998) "c-kit is expressed in Soft Tissue Sarcoma of neuroectodermis origin and its ligand prevents apoptosis of neoplastic cells", Blood, 91, 2397 — 2405.
- Landuzzi, L., De Giovanni, C., Nicoletti, G., Rossi, I., Ricci, C., Astolfi, A., et al. (2000) "The metastatic ability of Ewing's sarcoma cells is modulated by Stem Cell Factor and by its receptor c-kit", American Journal of Pathology, 157, 2123 — 2131.
- Pinto, A., Gloghini, A., Gattei, V., Aldinucci, D., Zagonel, V. and Carbone, A. (1994) "Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30 + anaplastic large cell lymphomas", Blood, 83, 785–792.
- Gruss, Hi., Brach, M.A., Drexler, HG., Bross, K.J. and Herrmann, F. (1992) "Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells", Cancer Research, 52, 1026— 1031.
- Merz, H., Houssiau, F.A., Orscheschek, K., Renauld, J.F., Fliedner, A., Herin, M., et al. (1991) "Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma", Blood, 78, 1311— 1317.
- Aldinucci, D. and Gattei, V. (2003) "The role of interleukin-3 and stem cell factor in classical Hodgkin disease", Blood, 101, 376 — 377.
- Gommerman, J.L. and Berger, S.A. (1998) "Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx", Blood, 91, 189 1— 1900.
- Fry, Ti. and Mackall, C.L. (2002) "Interleukin-7: from bench to clinic", Blood, 99, 3892–38904.
- Foss, H.D., Hummel, M., Gottstein, S., Ziemann, K., Falini, B., Herbst, H., et al., (1995) "Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease", Am J Pathol., 146, 33 — 39.
- Trumper, L., Jung, W., Dahl, G., Diehl, V., Gause, A. and Pfreundschuh, M. (1994) "Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease", Ann. °flea, 5, 93–96.
- Gorschluter, M., Bohlen, H., Hasenclever, D., Diehl, V. and Tesch, H. (1995) "Serum cytokine levels correlate with clinical parameters in Hodgkin's disease", Ann. Oncol., 6, 477–482.
- Touw, I., Pouwels, K., van Agthoven, T., van Gurp, R., Budel, L., Hoogerbrugge, H., et al. (1990) "Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia", Blood, 75, 2097 — 2101.
- Hsu, S.M., Waldron, J., Xie, S.S. and Hsu, P.L. (1995) "Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas", J. Biomed. Sci., 2, 302— 313.
- Kishimoto, T., Akira, S., Narazaki, M. and Taga, T. (1995) "Interleukin-6 family of cytokines and gp130", Blood, 86,1243 — 1254.
- Klein, B., Tarte, K., Jourdan, M., Mathouk, K., Moreaux, J., Jourdan, E., et al. (2003) "Survival and proliferation factors of normal and malignant plasma cells", Int. J. Hematol., 78, 106–113.
- Trikha, M., Corringham, R., Klein, B. and Rossi, J.F. (2003) "Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence", Clin. Cancer Res., 9, 4653–4665.
- Reynolds, G.M., Billingham, Li., Gray, L.J., Flavell, JR., Najafipour, S., Crocker, J., et al. (2002) "Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease", Br. J. Haematol., 118, 195–201.
- Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297— 303.
- Iwata, M., Graf, L., Awaya, N. and Torok-Storb, B. (2002) "Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein", Blood, 100, 1318–1325.
- Teruya-Feldstein, J., Tosato, G. and Jaffe, E.S. (2000) "The role of chemokines in Hodgkin's disease", Leuk. Lymphoma, 38, 363–371.
- Romagnani, S. (2002) "Cytokines and chemoattractants in allergic inflammation", Mol. Immunol., 38, 881 —885.
- Teruya-Feldstein, J., Jaffe, ES., Burd, P.R., Kingma, D.W., Setsuda, J.E. and Tosato, G. (1999) "Differential chemokine expression in tissues involved by Hodgkin's disease: direct correla-tion of eotaxin expression and tissue eosinophilia", Blood, 93, 2463–2470.
- Jundt, F., Anagnostopoulos, I., Bommert, K., Emmerich, F., Muller, G., Foss, H.D., et al. (1999) "Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils", Blood, 94, 2065 — 2071.
- Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P., et al. (1999) "Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta)", Proc. Natl. Acad. Sci. USA, 96, 9660–9665.
- Axdorph, U., Porwit-MacDonald, A., Grimfors, G. and Bjorkholm, M. (2001) "Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease", Leuk. Lymphoma, 42, 1055–1065.
- van Roozendaal, CE., van Ooijen, B., Klijn, J.G., Claassen, C., Eggermont, AM., Henzen-Logmans, S.C., et al. (1998) "Stromal influences on breast cancer cell growth", Br. J. Cancer, 65, 77–81.
- Gache, C., Berthois, Y., Cvitkovic, E., Martin, P.M. and Saez, S. (1999) "Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25-dihydroxyvitamin D3", Breast Cancer Res. Treat., 55, 29— 39.
- Gache, C., Berthois, Y., Martin, P.M. and Saez, S. (1998) "Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture", In Vitro Cell Dev. Biol. Anim., 34, 347–351.
- Noel, A. and Foidart, J.M. (1998) "The role of stroma in breast carcinoma growth in vivo", J. Mammary Gland Biol. Neoplasia, 3, 215 —225.
- Cunha, G.R., Hayward, SM. Wang, Y.Z. and Ricke, WA. (2003) "Role of the stromal microenvironment in carcinogenesis of the prostate", Int. J. Cancer, 20, 107, 1–10.
- De Weyer, 0. and Marcel, M. (2003) "Role of tissue stroma in cancer cell invasion", J. Pathol., 200, 429–447.
- Moinfar, F., Man, Y.G., Arnould, L., Bratthauer, G.L., Ratschek, M. and Tavassoli, F.A. (2000) "Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis", Cancer Res., 60, 2562— 2566.
- Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryck-mans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387–2396.
- Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V. (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", Br. J. Haematol., 92, 97–103.